HEC-80797

N/A

Report date: 2023/05/05 17:36:48
NME

Base Information

Drug NameHEC-80797
Drug Alias NameHEC-80797
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 6 inhibitorsCyclin-dependent kinase 4 inhibitors
TargetsCyclin-dependent kinase 6Cyclin-dependent kinase 4
Therapy Area/IndicationsBreast NeoplasmsLymphoma, Mantle-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDongguan Dongguan Sunshine Pharmaceutical Research and Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDongguan Dongguan Sunshine Pharmaceutical Research and Development Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast NeoplasmsLymphoma, Mantle-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A